
The timing exposes a hard industrial reality: the Air Force is betting that Raytheon can scale production while CENTCOM is actively drawing down inventory in the Gulf. If Iranian anti-ship or air-defense assets degrade Hormuz escort effectiveness, the service may face a choice between sustaining blockade operations and preserving munitions for a Pacific contingency.
Northrop Grumman's AGM-158C LRASM variant adds complexity — dual-source production doesn't exist, so any Raytheon constraint cascades to both platforms. The 5-7 year timeline also signals the service expects the Iran standoff to persist; a short-term procurement would have been 2-3 years.
This procurement surge locks in munitions capacity precisely when CENTCOM is consuming standoff missiles at combat tempo.
Raytheon's production line becomes the binding constraint — the company must scale from current output to deliver 1,600+ missiles annually, or the Air Force faces inventory depletion by late 2027 if the Hormuz standoff sustains. Watch whether the FY27 supplemental includes LRIP acceleration funding; if not, deliveries slip and the service loses surge inventory cover for a second major contingency (Taiwan, Korea, or renewed Iran operations).
What is Raytheon's current annual JASSM/LRASM production capacity, and has the company committed to the tooling and workforce expansion needed to hit 1,600+ units per year by 2028?
Strategic intelligence, synthesized daily — with a public track record. Every call graded against what actually happened.